Vol 10, No 3 (2014)

May/June

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents

Articles

Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: Results of in vitro laboratory analyses
Eric Galia, PhD, Yinka Williams, PhD, Ben Van Hove, Joseph Pergolizzi, MD, Mila Etropolski, MD, Gary Vorsanger, PhD, MD
PDF
149-158
Implementation of a collaborative care management program with buprenorphine in primary care: A comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically
Joji Suzuki, MD, Michele L. Matthews, PharmD, David Brick, BA, Minh-Thuy Nguyen, Robert N. N. Jamison, PhD, Andrew L. Ellner, MD, MSc, Lori W. Tishler, MD, Roger D. Weiss, MD
PDF
159-168
Patient aberrant drug taking behaviors in a large family medicine residency program: A retrospective chart review of screening practices, incidence, and predictors
Matthew Lewis, PharmD, Christopher M. Herndon, PharmD, BCPS, CPE, John T. Chibnall, PhD
PDF
169-175
Observations on hydrocodone and its metabolites in oral fluid specimens of the pain population: Comparison with urine
Jennifer M. Cao, BS, Joseph D. Ma, PharmD, Candis M. Morello, PharmD, CDE, Rabia S. Atayee, PharmD, BCPS, Brookie M. Best, PharmD, MAS
PDF
177-186
An evaluation of the performance of the Opioid Manager clinical tool in primary care: A qualitative study
Andrew Robertson, BSc, MD (Candidate), Sander L. Hitzig, PhD, Andrea D. Furlan, MD, PhD
PDF
187-199
A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center
Yatan Pal Singh Balhara, MD, DNB, MNAMS
PDF
200-206
A review of rapid-onset opioids for breakthrough pain in patients with cancer
Steven M. Simon, RPh, MD, Lee S. Schwartzberg, MD, FACP
PDF
207-215